---
annotation-target: 1-s2.0-S096808962200387X-main.pdf
---


>%%
>```annotation-json
>{"created":"2022-09-12T08:31:57.430Z","updated":"2022-09-12T08:31:57.430Z","document":{"title":"Ligand- and structure-based identification of novel CDK9 inhibitors for the potential treatment of leukemia","link":[{"href":"urn:x-pdf:114486f21280038b13652fa6f3d8cd80"},{"href":"vault:/hematology-theroy/papers/hematology_deeplearning/1-s2.0-S096808962200387X-main.pdf"}],"documentFingerprint":"114486f21280038b13652fa6f3d8cd80"},"uri":"vault:/hematology-theroy/papers/hematology_deeplearning/1-s2.0-S096808962200387X-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/hematology_deeplearning/1-s2.0-S096808962200387X-main.pdf","selector":[{"type":"TextPositionSelector","start":3111,"end":3678},{"type":"TextQuoteSelector","exact":"Cyclin-dependent kinases (CDKs) as members of serine/threonine protein kinases participate in the control of cell cycle progression (CDKs 1–6, 11 and 14–18) and cell transcription (CDKs 7–10, 12–13, 19 and 20) 1–3. The abnormal expression of CDKs can cause various malignant tumors, many efforts are exerted to discovery new drugs targeted CDKs 4,5,  especially  for  CDK9  subtype.  CDK9  is  a  component  of  positive transcription  elongation  factor  b  (P-TEFb),  which  functions  to  phos-phorylate the serine-2 at the C-terminal domain of RNA polymerase II t","prefix":" of leukemia.   1. Introduction ","suffix":"o stimulate the transcription el"}]}]}
>```
>%%
>*%%PREFIX%%of leukemia.   1. Introduction%%HIGHLIGHT%% ==Cyclin-dependent kinases (CDKs) as members of serine/threonine protein kinases participate in the control of cell cycle progression (CDKs 1–6, 11 and 14–18) and cell transcription (CDKs 7–10, 12–13, 19 and 20) 1–3. The abnormal expression of CDKs can cause various malignant tumors, many efforts are exerted to discovery new drugs targeted CDKs 4,5,  especially  for  CDK9  subtype.  CDK9  is  a  component  of  positive transcription  elongation  factor  b  (P-TEFb),  which  functions  to  phos-phorylate the serine-2 at the C-terminal domain of RNA polymerase II t== %%POSTFIX%%o stimulate the transcription el*
>%%LINK%%[[#^rs991n6rru|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^rs991n6rru


>%%
>```annotation-json
>{"created":"2022-09-12T08:33:17.643Z","updated":"2022-09-12T08:33:17.643Z","document":{"title":"Ligand- and structure-based identification of novel CDK9 inhibitors for the potential treatment of leukemia","link":[{"href":"urn:x-pdf:114486f21280038b13652fa6f3d8cd80"},{"href":"vault:/hematology-theroy/papers/hematology_deeplearning/1-s2.0-S096808962200387X-main.pdf"}],"documentFingerprint":"114486f21280038b13652fa6f3d8cd80"},"uri":"vault:/hematology-theroy/papers/hematology_deeplearning/1-s2.0-S096808962200387X-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/hematology_deeplearning/1-s2.0-S096808962200387X-main.pdf","selector":[{"type":"TextPositionSelector","start":13520,"end":14206},{"type":"TextQuoteSelector","exact":"Therefore, four graph-based predictive models (Table S2) were developed using the four advanced DL algo-rithms (i.e. GCN, GAT, Attentive FP and FP-GNN). FP-GNN as a novel DL algorithm  developed  in  our  Lab  (https://github.com/idrugL ab/FP-GNN), can operate over a hybrid molecular feature representa-tion that combines molecular graph and fingerprints. FP-GNN archi-tecture  can  achieve  SOTA  performance  for  molecular  properties prediction  tasks  (data  not  shown).  Taking  the  BA  score  (Fig.  3  and Table 1) of the testing set into consideration, FP-GNN method displayed the overall best performance compared with other GNN methods, with the highest BA value of 0.681.","prefix":"activity and ADME/T properties. ","suffix":" Comparisons of the established "}]}]}
>```
>%%
>*%%PREFIX%%activity and ADME/T properties.%%HIGHLIGHT%% ==Therefore, four graph-based predictive models (Table S2) were developed using the four advanced DL algo-rithms (i.e. GCN, GAT, Attentive FP and FP-GNN). FP-GNN as a novel DL algorithm  developed  in  our  Lab  (https://github.com/idrugL ab/FP-GNN), can operate over a hybrid molecular feature representa-tion that combines molecular graph and fingerprints. FP-GNN archi-tecture  can  achieve  SOTA  performance  for  molecular  properties prediction  tasks  (data  not  shown).  Taking  the  BA  score  (Fig.  3  and Table 1) of the testing set into consideration, FP-GNN method displayed the overall best performance compared with other GNN methods, with the highest BA value of 0.681.== %%POSTFIX%%Comparisons of the established*
>%%LINK%%[[#^irysvke8rwd|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^irysvke8rwd
